Werewolf Therapeutics, Inc. (HOWL) DCF Valuation

Werewolf Therapeutics, Inc. (HOWL) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Werewolf Therapeutics, Inc. (HOWL) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore Werewolf Therapeutics, Inc.'s (HOWL) financial outlook with our user-friendly DCF Calculator! Enter your projections for growth, margins, and expenses to determine Werewolf Therapeutics, Inc.'s (HOWL) intrinsic value and enhance your investment strategy.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 16.4 19.9 21.0 22.2 23.4 24.6 25.9
Revenue Growth, % 0 0 0 0 21.6 5.4 5.4 5.4 5.4 5.4
EBITDA -9.4 -14.3 -49.2 -51.3 -32.5 4.2 4.4 4.7 4.9 5.2
EBITDA, % 100 100 100 -312.79 -162.79 20 20 20 20 20
Depreciation .5 .8 .7 2.5 1.8 13.6 14.4 15.1 16.0 16.8
Depreciation, % 100 100 100 15.3 8.85 64.83 64.83 64.83 64.83 64.83
EBIT -9.9 -15.0 -50.0 -53.8 -34.2 4.2 4.4 4.7 4.9 5.2
EBIT, % 100 100 100 -328.09 -171.63 20 20 20 20 20
Total Cash 17.9 92.6 157.5 129.3 134.3 21.0 22.2 23.4 24.6 25.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 6.9 1.4
Account Receivables, % 100 100 100 42.24 6.77
Inventories .0 .0 .0 .0 .0 12.6 13.3 14.0 14.8 15.6
Inventories, % 100 100 100 0.000012194378 0 60 60 60 60 60
Accounts Payable .6 1.0 2.0 1.2 1.3 13.2 13.9 14.7 15.5 16.3
Accounts Payable, % 100 100 100 7.44 6.7 62.83 62.83 62.83 62.83 62.83
Capital Expenditure -.3 -.6 -.5 -3.6 -.8 -1.1 -1.1 -1.2 -1.3 -1.3
Capital Expenditure, % 100 100 100 -22.02 -3.86 -5.17 -5.17 -5.17 -5.17 -5.17
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -10.6 -14.9 -49.8 -51.6 -34.2 4.2 4.4 4.6 4.9 5.1
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -9.8 -14.3 -48.5 -60.4 -27.5 2.6 16.8 17.7 18.7 19.7
WACC, % 6.23 6.21 6.22 6.11 6.23 6.2 6.2 6.2 6.2 6.2
PV UFCF
SUM PV UFCF 61.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 20
Terminal Value 479
Present Terminal Value 355
Enterprise Value 416
Net Debt -82
Equity Value 498
Diluted Shares Outstanding, MM 36
Equity Value Per Share 13.98

What You Will Receive

  • Customizable Excel Template: A fully adjustable Excel-based DCF Calculator featuring pre-filled real HOWL financial data.
  • Authentic Data: Historical performance metrics and forward-looking projections (highlighted in the yellow cells).
  • Flexible Forecasting: Modify key assumptions such as revenue growth, EBITDA %, and WACC.
  • Instant Calculations: Quickly observe how your inputs affect Werewolf Therapeutics’ valuation.
  • Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
  • Intuitive Design: Organized for clarity and ease of navigation, complete with step-by-step guidance.

Key Features

  • 🔍 Real-Life HOWL Financials: Pre-filled historical and projected data for Werewolf Therapeutics, Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Werewolf Therapeutics’ intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Werewolf Therapeutics’ valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • 1. Access the Template: Download and open the Excel file featuring Werewolf Therapeutics, Inc. (HOWL) preloaded data.
  • 2. Modify Assumptions: Adjust essential inputs such as growth rates, WACC, and capital expenditures.
  • 3. View Results Instantly: The DCF model automatically calculates intrinsic value and NPV in real-time.
  • 4. Explore Scenarios: Analyze various forecasts to evaluate different valuation outcomes.
  • 5. Present with Confidence: Deliver professional valuation insights to bolster your decision-making process.

Why Choose This Calculator for Werewolf Therapeutics, Inc. (HOWL)?

  • Accurate Data: Utilize real Werewolf Therapeutics financials for dependable valuation outcomes.
  • Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Pre-configured calculations streamline your process, avoiding the need to begin from scratch.
  • Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Easy-to-navigate design and step-by-step guidance cater to users of all experience levels.

Who Should Use This Product?

  • Investors: Accurately assess Werewolf Therapeutics, Inc.'s (HOWL) fair value prior to making investment decisions.
  • CFOs: Utilize a professional-grade DCF model for comprehensive financial reporting and analysis.
  • Consultants: Easily customize the template for valuation reports tailored to clients in the biotech sector.
  • Entrepreneurs: Acquire insights into financial modeling practices utilized by leading biotech firms.
  • Educators: Employ it as a teaching resource to illustrate valuation methodologies specific to the pharmaceutical industry.

What the Template Contains

  • Pre-Filled Data: Includes Werewolf Therapeutics’ historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze Werewolf Therapeutics’ profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.